tiprankstipranks
Trending News
More News >
CanadaBis Capital, Inc. (TSE:CANB)
:CANB
Canadian Market

CanadaBis Capital (CANB) AI Stock Analysis

Compare
14 Followers

Top Page

TSE:CANB

CanadaBis Capital

(CANB)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 4o)
Rating:44Neutral
Price Target:
C$0.02
▲(20.00% Upside)
CanadaBis Capital's overall stock score is primarily impacted by its financial performance and technical analysis. The company's financial challenges, including declining revenues and negative cash flows, are significant concerns. Additionally, the bearish technical indicators reflect weak market sentiment. The valuation score is moderate but reflects the company's unprofitability and lack of dividend yield.
Positive Factors
Operational Efficiency
A healthy gross profit margin indicates operational efficiency, which can help the company manage costs effectively and sustain operations despite other financial challenges.
Strategic Partnerships
Strategic partnerships provide access to new revenue opportunities and strengthen market position, supporting long-term growth and stability in the competitive cannabis sector.
Balanced Asset Structure
A stable equity ratio indicates a balanced asset structure, which can provide financial stability and resilience against market fluctuations, supporting long-term business sustainability.
Negative Factors
Declining Revenue
Declining revenue indicates challenges in market demand or competitive positioning, which can impact the company's ability to grow and maintain profitability in the long term.
Negative Cash Flows
Negative cash flows from operations suggest liquidity issues, which can hinder the company's ability to invest in growth opportunities and meet financial obligations, affecting long-term viability.
Rising Leverage
Rising leverage can increase financial risk and limit flexibility, making it challenging for the company to navigate economic downturns or invest in strategic initiatives, impacting long-term stability.

CanadaBis Capital (CANB) vs. iShares MSCI Canada ETF (EWC)

CanadaBis Capital Business Overview & Revenue Model

Company DescriptionCanadaBis Capital (CANB) is a diversified investment and holding company based in Canada, primarily focused on the cannabis sector, as well as other emerging industries. The company seeks to capitalize on opportunities within the legal cannabis market, offering financial resources and strategic support to businesses engaged in cultivation, distribution, and retail. In addition to cannabis, CanadaBis Capital explores investments in technology and health sectors, aiming to build a balanced portfolio that leverages market trends and growth potential.
How the Company Makes MoneyCanadaBis Capital generates revenue through a combination of equity investments, strategic partnerships, and advisory services. The company invests in cannabis-related businesses, acquiring equity stakes that yield returns through dividends and capital appreciation as these companies grow. Additionally, CanadaBis Capital provides advisory services to its portfolio companies, earning fees for strategic guidance and operational support. Significant partnerships with established industry players enhance its market position and provide access to new revenue opportunities, while ongoing market demand for cannabis products contributes to the financial performance of its investments.

CanadaBis Capital Financial Statement Overview

Summary
CanadaBis Capital faces significant financial challenges, with declining revenues, negative profitability, and cash flow issues. While the company maintains some operational efficiency, as seen in its gross profit margin, the increasing leverage and inability to generate positive cash flows are concerning.
Income Statement
45
Neutral
CanadaBis Capital has experienced declining revenue over the past year, with a negative revenue growth rate of -1.52%. The company is currently unprofitable, as indicated by a negative net income and net profit margin. However, the gross profit margin remains relatively healthy, suggesting some operational efficiency. The EBIT and EBITDA margins have decreased significantly compared to previous years, indicating challenges in maintaining profitability.
Balance Sheet
50
Neutral
The balance sheet shows a moderate debt-to-equity ratio, which has increased over the past year, indicating rising leverage. The equity ratio is stable, suggesting a balanced asset structure. However, the return on equity has turned negative, reflecting the company's current unprofitability and potential challenges in generating returns for shareholders.
Cash Flow
40
Negative
The cash flow statement reveals negative operating and free cash flows, indicating cash outflows from operations. Although there is a slight improvement in free cash flow growth, the company struggles to convert net income into positive cash flow, as evidenced by the negative operating cash flow to net income ratio. This poses a risk to liquidity and operational sustainability.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue16.90M16.90M17.95M22.22M11.67M6.87M
Gross Profit7.33M6.98M8.82M11.78M5.57M2.52M
EBITDA800.06K800.05K2.09M5.68M1.57M-1.81M
Net Income-835.20K-835.20K600.28K4.44M608.33K-2.68M
Balance Sheet
Total Assets24.54M24.54M24.55M22.96M15.48M13.28M
Cash, Cash Equivalents and Short-Term Investments831.06K831.06K1.68M3.23M144.88K849.50K
Total Debt7.75M7.75M6.44M7.31M7.82M8.44M
Total Liabilities17.83M17.83M16.45M15.62M12.84M11.46M
Stockholders Equity6.62M6.62M8.00M7.25M2.54M1.73M
Cash Flow
Free Cash Flow-3.37M-3.37M-594.48K4.57M-292.54K-1.96M
Operating Cash Flow-3.20M-3.20M-256.31K5.55M-82.77K-1.81M
Investing Cash Flow-169.65K-169.65K-328.33K-965.82K-209.77K122.77K
Financing Cash Flow2.52M2.52M-962.02K-1.50M-412.09K2.37M

CanadaBis Capital Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.02
Price Trends
50DMA
0.04
Negative
100DMA
0.04
Negative
200DMA
0.05
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
0.12
Positive
STOCH
-38.89
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CANB, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.03, below the 50-day MA of 0.04, and below the 200-day MA of 0.05, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 0.12 is Positive, neither overbought nor oversold. The STOCH value of -38.89 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CANB.

CanadaBis Capital Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
55
Neutral
$13.29B17.4210.03%0.93%7.13%-12.93%
45
Neutral
$8.19M-1.99-93.87%-0.74%81.49%
44
Neutral
C$3.46M-4.17-11.42%-5.87%-239.53%
41
Neutral
C$3.84M-1.331.60%-213.10%
24
Underperform
$6.92M-1.2615.64%58.47%
* Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:CANB
CanadaBis Capital
0.02
-0.02
-50.00%
TSE:KHRN.H
Khiron Life Sciences
0.04
0.00
0.00%
TSE:PCLO
PharmaCielo
0.05
-0.04
-47.06%
TSE:SPR
Sproutly Canada
0.02
0.00
0.00%
TSE:CDVA
CordovaCann
0.04
>-0.01
-12.50%
IMCC
IM Cannabis Corp
1.56
-0.64
-29.09%

CanadaBis Capital Corporate Events

Business Operations and StrategyFinancial Disclosures
CanadaBis Capital Achieves Positive Q3 2025 Financial Results Amid Market Challenges
Positive
Jul 2, 2025

CanadaBis Capital has reported its financial results for Q3 2025, achieving a positive adjusted EBITDA of $440,665 despite a challenging market environment. The company recorded gross sales of $5.5 million and a 6% increase in gross earnings over previous periods. Strategic cost management and product innovation, including the launch of diamond and Keef-coated pre-rolls, have been pivotal in maintaining operational efficiency. Additionally, CanadaBis has reduced its short-term debt by $2.5 million and plans to launch innovative vape hardware later this year, positioning itself for future growth in the cannabis sector.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 19, 2025